1Kesisoglou F, Panmai S, Wu Y. Nanosizing oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev, 2007, 59(7): 631.
2Van Eerdenbrugh B, Froyen L, Martens JA, et al. Characterization of physico-chernical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti HIV agent loviride prepared by media milling. Int J Pharm, 2007, 338(1-2) : 198.
3Vogt M, Kunath K, Dressman JB, Dissolution enhancement of fenofibrate by micronization, cogrinding and spray drying: comparison with commercial preparations. Eur J Pharm Biopharm, 2008, 68(2): 283.
4Jung JY, Yoo SD, Lee SH, et al. Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. Int J Pharm, 1999, 187(2): 209.
5Al-Marzouqi HA, Elwy MH, Shehadi I, et al. Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supereritical carbon dioxide and by conventional techniques. J Pharm Biomed Anal, 2009, 49(2): 227.
6Kassem MA, Abdel Rahman AA, Ghorab MM, et al. nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm, 2007, 340(1-2):126.
7Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov, 2004, 3(9): 785.
8Liversidge GG, Cundy CK. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs:1. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm, 1995, 125(1) : 91.
9Kayser O, Olbrich C, Yardley V, et al. Formulation of amphotericin B as nanosuspension of oral administration. Int J Pharm, 2003, 254 (1) : 73.
10Van Eerdenbrugh B, Van den Mooter G, Augustijns P. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm, 2008, 364(1): 64.
2RH Muller, R Becker, B Kruss, et al. Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution[P]. United States Patent 5,858,410, Medac Geseitschaft far Klinische Spezialpraparate mbH, 1999.
3Claudia Jacobs, Rainer Helmut Muller. Production and characterization of a budesonide nanosuspension for pulmonary administration[J]. Pharm Res, 2002,19(2): 189-194.
4C Jacobs, O Kayser, RH Mfiller. Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide[J]. Int J Pharm, 2000, 196(2) : 161-164.
5K Peters, S Leitzke, JE Diederichs, et al. Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection[J]. J Antimicrob Chemother, 2000, 45 (1) : 77-83.
6KP Krause, O Kayser, K Mader, et al. Heavy metal contamination of nanosuspensions produced by high-pressure homogenisation[J]. Int J Pharrn,2000,196(2) : 169-172.
7JE Kipp, Wong, JCT, et al. Microprecipitation Method For Preparing Submieron Suspensions[P]. United States Patent 6,607,784, Baxter International Inc. (Deerfield, IL), USA, 2003.
8Henriksen, Mishra, Pace, et al. Insoluble drug delievery[P], International Patent 97/14407, Triangle Pharmaceuticals, The university of Texas system, April 24,1997.
9James E. Kipp, Mark J. Doty,CL. Rebbeck, etal. Compositions of and Method for Preparing Stable Partieiles in a Frozen Aqueous Matrix[P], United States Patent 7,112,340, Baxter International Inc. (Deerfield, IL) Sep. 26, 2006.
10Vergnauh,Grenier, Nhamias, et al. Method for The Preparation of Pharmaceutical Nanosuspensions Using Supersonic Fluid Flow[P]. Ep Patent WO 03/045353, June 5, 2003.
5Lei Gao,Guiyang Liu,Jianli Ma,Xiaoqing Wang,Liang Zhou,Xiang Li.Drug nanocrystals: In vivo performances[J].Journal of Controlled Release.2012(3)
6Jonathan M. Miller,Arik Dahan.Predicting the solubility–permeability interplay when using cyclodextrins in solubility-enabling formulations: Model validation[J].International Journal of Pharmaceutics (-).2012(1-2)
7Jaime Salazar,Oliver Heinzerling,Rainer H. Müller,Jan P. M?schwitzer.Process optimization of a novel production method for nanosuspensions using design of experiments (DoE)[J].International Journal of Pharmaceutics.2011(2)
8Rainer H. Müller,Sven Gohla,Cornelia M. Keck.State of the art of nanocrystals – Special features, production, nanotoxicology aspects and intracellular delivery[J].European Journal of Pharmaceutics and Biopharmaceutics.2011(1)
9Libo Wu,Jian Zhang,Wiwik Watanabe.Physical and chemical stability of drug nanoparticles[J].Advanced Drug Delivery Reviews.2011(6)
10Surajit Das,Wai Kiong Ng,Parijat Kanaujia,Sanggu Kim,Reginald B.H. Tan.Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: Effects of process variables[J].Colloids and Surfaces B: Biointerfaces.2011(1)
